E. faecium E. faecalis Erythromycin, ERY Gentamicin, GEN Linezolid, LZD Quin.-Dalf. (Synercid), SYN Teicoplanin, TEI Tetracycline, TET Tigecycline, TGC Vancomycin, VAN Strain Antimicrobial Results and interpretation > MIC-value (μg/ml) S / R Enterococci EURL ENT. 11.2 E. faecium E. faecalis Ampicillin AMP Chloramphenicol, CHL Ciprofloxacin, CIP Daptomycin, DAP Erythromycin, ERY Gentamicin, GEN Linezolid, LZD Quin.-Dalf. (Synercid), SYN Teicoplanin, TEI Tetracycline, TET Tigecycline, TGC Vancomycin, VAN TEST FORM - Enterococci Strain Antimicrobial Results and interpretation > MIC-value (μg/ml) S / R Enterococci EURL ENT. 11.3 E. faecium Ampicillin AMP Chloramphenicol, CHL Ciprofloxacin, CIP Daptomycin, DAP Erythromycin, ERY Gentamicin, GEN
E. faecalis Linezolid, LZD Quin.-Dalf. (Synercid), SYN Teicoplanin, TEI Tetracycline, TET Tigecycline, TGC Vancomycin, VAN Strain Antimicrobial Results and interpretation > MIC-value (μg/ml) S / R Enterococci EURL ENT. 11.4 E. faecium E. faecalis Ampicillin AMP Chloramphenicol, CHL Ciprofloxacin, CIP Daptomycin, DAP Erythromycin, ERY Gentamicin, GEN Linezolid, LZD Quin.-Dalf. (Synercid), SYN Teicoplanin, TEI Tetracycline, TET Tigecycline, TGC Vancomycin, VAN TEST FORM - Enterococci Strain Antimicrobial Results and interpretation > MIC-value (μg/ml) S / R Enterococci EURL ENT. 11.5 E. faecium E. faecalis Ampicillin AMP Chloramphenicol, CHL Ciprofloxacin, CIP Daptomycin, DAP Erythromycin, ERY Gentamicin, GEN Linezolid, LZD Quin.-Dalf. (Synercid), SYN
Teicoplanin, TEI Tetracycline, TET Tigecycline, TGC Vancomycin, VAN Strain Antimicrobial Results and interpretation > MIC-value (μg/ml) S / R Enterococci EURL ENT. 11.6 E. faecium E. faecalis Ampicillin AMP Chloramphenicol, CHL Ciprofloxacin, CIP Daptomycin, DAP Erythromycin, ERY Gentamicin, GEN Linezolid, LZD Quin.-Dalf. (Synercid), SYN Teicoplanin, TEI Tetracycline, TET Tigecycline, TGC Vancomycin, VAN TEST FORM - Enterococci Strain Antimicrobial Results and interpretation > MIC-value (μg/ml) S / R Enterococci EURL ENT. 11.7 E. faecium E. faecalis Ampicillin AMP Chloramphenicol, CHL Ciprofloxacin, CIP Daptomycin, DAP Erythromycin, ERY Gentamicin, GEN Linezolid, LZD Quin.-Dalf. (Synercid), SYN Teicoplanin, TEI Tetracycline, TET
Teicoplanin, TEI Tetracycline, TET Tigecycline, TIG Vancomycin, VAN TEST FORMS - Staphylococci Strain Antimicrobial Results and interpretation > MIC-value (μg/ml) S / R S. aureus EURL ST 11.1 Cefoxitin, FOX Chloramphenicol, CHL Ciprofloxacin, CIP Clindamycin, CLN Erythromycin, ERY Gentamicin, GEN Linezolid, LZD Mupirocin, MUP Quinu-dalfopristin (Synercid), SYN Sulfamethoxazole, SMX Sulfamethoxazole+Trimethoprim, SXT Tetracycline, TET Tiamulin, TIA Trimethoprim, TMP Vancomycin, VAN Methicillin resistance (MRSA) Positive Negative TEST FORMS - Staphylococci
E. coli EURL EC 11.1 Ampicillin, AMP Azithromycin, AZT Cefotaxime, FOT Ceftazidime, TAZ Chloramphenicol, CHL Ciprofloxacin CIP Colistin, COL Gentamicin, GEN Meropenem, MERO Nalidixic acid, NAL Sulfamethoxazole, SMX Tetracycline, TET Tigecycline, TGC Trimethoprim, TMP All strains resistant to cefotaxime (FOT), ceftazidime (TAZ) or meropenem (MERO) should be included for testing in the second panel confirmatory tests for ESBL or carbapenemase production. See further description of confirmatory tests in the protocol section ‘3.1.1 E. coli’. Strain Antimicrobial Results and interpretation > MIC-value (μg/ml) S / R E. coli EURL EC 11.1 Cefepime, FEP Cefotaxime, FOT Cefotaxime + clavulanic acid (F/C) Cefoxitin, FOX Ceftazidime, TAZ Ceftazidime+ clavulanic acid (T/C) Ertapenem, ETP Imipenem, IMI Meropenem, MERO Temocillin, TRM Interpretation of PANEL 2 results: Presumptive ESBL Presumptive ESBL+ AmpC Presumptive AmpC Presumptive carbapenemase Other phenotype Susceptible Comments (include optional genotype or other results): TEST FORM – E. coli Strain Antimicrobial Results and interpretation
> MIC-value (μg/ml) S / R E. coli EURL EC 11.8 Ampicillin, AMP Azithromycin, AZT Cefotaxime, FOT Ceftazidime, TAZ Chloramphenicol, CHL Ciprofloxacin CIP Colistin, COL Gentamicin, GEN Meropenem, MERO Nalidixic acid, NAL Sulfamethoxazole, SMX Tetracycline, TET Tigecycline, TGC Trimethoprim, TMP All strains resistant to cefotaxime (FOT), ceftazidime (TAZ) or meropenem (MERO) should be included for testing in the second panel confirmatory tests for ESBL or carbapenemase production. See further description of confirmatory tests in the protocol section ‘3.1.1 E. coli’. Strain Antimicrobial Results and interpretation > MIC-value (μg/ml) S / R E. coli EURL EC 11.8 Cefepime, FEP Cefotaxime, FOT Cefotaxime + clavulanic acid (F/C) Cefoxitin, FOX Ceftazidime, TAZ Ceftazidime+ clavulanic acid (T/C) Ertapenem, ETP Imipenem, IMI Meropenem, MERO Temocillin, TRM Interpretation of PANEL 2 results: Presumptive ESBL Presumptive ESBL+ AmpC Presumptive AmpC Presumptive carbapenemase Other phenotype Susceptible